Postural orthostatic tachycardia syndrome, or POTS, rarely traces back to a single cause. Most people who develop it can point to a triggering event, whether an infection, a surgery, or a period of prolonged bed rest, but the reason their body responds by losing control of heart rate upon standing involves a tangle of factors that researchers are still sorting out. What makes POTS particularly frustrating to pin down is that different patients appear to arrive at the same set of symptoms through very different pathways, from damaged nerves to misfiring immune cells to inherited gene mutations.
Infections as the Most Common Starting Point
If you ask people with POTS when their symptoms began, a viral or bacterial infection is the most frequently cited trigger. COVID-19 has become the highest-profile example. Among people with persistent long COVID symptoms, roughly a third meet the diagnostic criteria for POTS, according to a study of highly symptomatic long COVID patients.1PubMed. Prevalence and Clinical Impact of Postural Orthostatic Tachycardia Syndrome in Highly Symptomatic Long COVID The condition has also been documented after COVID-19 in adolescents, a population not typically associated with heart-rate disorders.2PubMed Central. Successful treatment of long-COVID postural tachycardia syndrome with epipharyngeal abrasive therapy in an adolescent patient
COVID-19 did not invent post-infectious POTS, though. Lyme disease, mononucleosis, influenza, and other infections have all preceded POTS onset. In the case of Lyme disease, some patients develop persistent orthostatic intolerance even after completing antibiotic treatment, with symptoms that overlap substantially with POTS.3PubMed Central. A tale of two syndromes: Lyme disease preceding postural orthostatic tachycardia syndrome The proposed link is that illness can alter immune activity or damage autonomic nerves, leaving the cardiovascular system unable to properly compensate when you stand up. Not everyone who gets a serious infection develops POTS afterward, which suggests that some people carry a vulnerability, whether genetic, immunological, or structural, that makes the post-infectious cascade more likely to stick.
The Autoimmune Question
One of the more debated ideas in POTS research is whether the condition is fundamentally autoimmune in at least some patients. The theory goes like this: after an infection or other immune challenge, the body produces antibodies that mistakenly target receptors involved in heart rate and blood vessel control. If those antibodies interfere with how your autonomic nervous system communicates, the result could be POTS symptoms.
Supporting this idea, one study detected elevated levels of autoantibodies against adrenergic alpha-1 receptors in about 89% of POTS patients and against muscarinic acetylcholine M4 receptors in about 53%.4PubMed Central. Postural Orthostatic Tachycardia Syndrome Is Associated With Elevated G-Protein Coupled Receptor Autoantibodies Those are high numbers, and they fueled considerable excitement. But a subsequent study using more standardized laboratory methods found no meaningful difference in autoantibody concentrations between POTS patients and healthy controls, concluding that standard antibody tests are not useful for establishing an autoimmune basis for POTS.5PubMed Central. Detection of G Protein-Coupled Receptor Autoantibodies in Postural Orthostatic Tachycardia Syndrome Using Standard Methodology
This disagreement has not been fully resolved. It may come down to which laboratory technique is used: the cell-based bioassays in earlier studies may detect something the standard enzyme-linked tests miss, or they may produce more false positives. For now, “autoimmune POTS” remains a plausible category rather than a proven one. Researchers continue to investigate whether specific subsets of patients have genuine antibody-driven disease, but no blood test can confirm it yet.
Genetic Roots
POTS is not typically thought of as a genetic disease, but family patterns and specific mutations show that inherited factors play a real role. The clearest example involves a mutation in the norepinephrine transporter gene, SLC6A2. Norepinephrine is the chemical messenger your sympathetic nervous system uses to constrict blood vessels and speed up the heart. A transporter protein normally clears norepinephrine from the synaptic gap after it has done its job. In one well-studied family, researchers found a single-letter mutation that knocked out more than 98% of that transporter’s function.6PubMed. Orthostatic intolerance and tachycardia associated with norepinephrine-transporter deficiency The result was that norepinephrine lingered far too long, causing exaggerated heart rate spikes and blood pressure swings when standing. The mutant version of the gene tracked with elevated heart rates and norepinephrine levels across multiple family members.7PubMed Central. A mutation in the human norepinephrine transporter gene (SLC6A2) associated with orthostatic intolerance disrupts surface expression of mutant and wild-type transporters
Beyond that specific mutation, broader family studies suggest a pattern of dominant transmission with incomplete penetrance, meaning the gene variant can be passed from parent to child but does not always produce symptoms. A study of 16 families with adolescents who had orthostatic intolerance found vertical transmission consistent with a dominant genetic syndrome, though the sex ratio was skewed, with more females affected.8PubMed Central. Dominant Transmission Observed in Adolescents and Families With Orthostatic Intolerance These findings point to a genetic susceptibility layer: you might inherit a predisposition that makes you more vulnerable to POTS when an environmental trigger comes along.
Connective Tissue Disorders and Joint Hypermobility
Clinicians who treat POTS have long noticed that an unusual number of their patients also have hypermobile joints, often meeting criteria for Ehlers-Danlos syndrome, hypermobility type (now called hypermobile EDS). Orthostatic intolerance was present in about 74% of people with hypermobile EDS compared with 34% of controls in one study, and the most common form it took was postural tachycardia.9PubMed. Dysautonomia and its underlying mechanisms in the hypermobility type of Ehlers-Danlos syndrome Connective tissue laxity was identified as an aggravating factor in autonomic dysfunction in that same study.
The proposed mechanism is mechanical. If your veins and surrounding tissues are stretchier than normal, blood pools more easily in the legs and pelvis when you stand. That pooling reduces the amount of blood returning to the heart, which triggers a compensatory spike in heart rate. The connective tissue abnormalities in EDS may also predispose patients to vein compression, making the pooling worse.10PubMed Central. May-Thurner syndrome in patients with postural orthostatic tachycardia syndrome and Ehlers-Danlos syndrome This creates something of a vicious cycle: excessive venous stretch leads to blood pooling, which leads to sympathetic overdrive, which produces the racing heart and lightheadedness that define POTS.
Low Blood Volume and Peripheral Nerve Damage
Two of the best-characterized physiological abnormalities in POTS patients are low blood volume and damage to small nerve fibers in the legs. These can operate independently or together, and they represent different “subtypes” of the condition.
On the blood volume side, patients with POTS have been found to have markedly lower plasma volume and total blood volume than healthy people. One study measured the deficit at nearly 700 mL less total blood volume on average in POTS patients compared with controls.11PubMed. Renin-aldosterone paradox and perturbed blood volume regulation underlying postural tachycardia syndrome What made this especially puzzling was that the normal hormonal response to low blood volume, an increase in renin and aldosterone that tells the kidneys to retain fluid, was blunted. Aldosterone was paradoxically low in the POTS group despite their obvious need for more blood volume. Many POTS patients also show elevated upright norepinephrine levels, reflecting a sympathetic nervous system that is working overtime to compensate for inadequate circulation.12PubMed Central. The Postural Tachycardia Syndrome (POTS): pathophysiology, diagnosis & management
On the nerve damage side, researchers have documented small fiber neuropathy predominantly in the lower body. Evidence includes impaired sweating in the feet and legs, reduced norepinephrine release in lower limb veins, and loss of nerve fibers visible on skin biopsy.13PubMed Central. Structural and Functional Small Fiber Abnormalities in the Neuropathic Postural Tachycardia Syndrome When the nerves that tell leg veins to constrict are damaged, blood settles downward on standing, and the heart has to compensate by beating faster. This form, called neuropathic POTS, may explain why so many post-infectious cases behave the way they do: infections can selectively damage small autonomic nerve fibers.
Hormones and the Menstrual Cycle
POTS overwhelmingly affects women, with estimates ranging from a 4:1 to 5:1 female-to-male ratio. This skew has led researchers to examine whether sex hormones modulate the condition. The evidence suggests they do. During phases of the menstrual cycle when estrogen and progesterone are both high, the renin-angiotensin-aldosterone system, which governs fluid retention, responds more robustly. That extra fluid retention appears to improve standing tolerance for women with POTS during the late luteal phase.14PubMed Central. Menstrual cycle affects renal-adrenal and hemodynamic responses during prolonged standing in the postural orthostatic tachycardia syndrome
Conversely, many women with POTS report that their lightheadedness worsens at specific points in their cycle, likely corresponding to drops in estrogen. Patients with POTS also report higher rates of estrogen-related gynecologic conditions.15PubMed Central. Gynecologic disorders and menstrual cycle lightheadedness in postural tachycardia syndrome Whether hormonal fluctuations cause POTS, worsen an existing predisposition, or simply make symptoms more noticeable remains an open question. Pregnancy adds another layer of complexity: symptom course during pregnancy and the postpartum period is highly variable, with some women improving and others getting significantly worse.16PubMed. Postural Orthostatic Tachycardia Syndrome during pregnancy: A systematic review of the literature
Deconditioning and the Chicken-or-Egg Problem
Physical inactivity consistently appears in the background of POTS patients, though it occupies an awkward position in the causal story. Almost all POTS patients have some degree of cardiovascular deconditioning, and research has linked a smaller-than-normal heart to the condition, a finding consistent with prolonged bed rest or inactivity.17PubMed Central. Cardiac Origins of the Postural Orthostatic Tachycardia Syndrome The question is whether deconditioning causes POTS or whether POTS causes deconditioning. In many cases, it is probably both. Someone gets an infection, develops fatigue and orthostatic symptoms, reduces their activity level, and that inactivity makes the cardiovascular system even less able to handle standing. This feedback loop helps explain why graded exercise programs are one of the most effective treatments: they break the cycle from the deconditioning end even if they do not address the original trigger.
Mast Cell Activation
A subset of POTS patients experience flushing, hives, gastrointestinal distress, or other symptoms that suggest their mast cells, immune cells involved in allergic reactions, are overly active. When researchers screened a group of POTS patients for mast cell activation disorder, about 42% showed both the clinical symptoms and at least one elevated biochemical marker of mast cell activity, such as elevated prostaglandins or plasma histamine.18Journal of the American Heart Association. Mast Cell Activation Disorder and Postural Orthostatic Tachycardia Syndrome: A Clinical Association Mast cells release chemicals that dilate blood vessels and can trigger rapid heart rate, so the overlap with POTS symptoms makes mechanistic sense. Whether mast cell activation causes POTS, shares an upstream trigger with it, or is simply a commonly co-occurring condition remains unclear. For patients who have both, treating the mast cell component with antihistamines and mast cell stabilizers sometimes helps the POTS symptoms too, which is at least suggestive of a functional link.
Vascular Compression Syndromes
An area of growing clinical interest involves structural compression of veins in the abdomen, pelvis, or neck. Conditions like May-Thurner syndrome, where the left common iliac vein is compressed between the spine and an artery, and Nutcracker syndrome, where the left renal vein is similarly pinched, are turning up at higher rates in POTS patients than in the general population.19PubMed. Pelvic venous disorders and orthostatic intolerance: A systematic review of diagnostic associations and treatment outcomes A broader review of vascular compression syndromes found that they can impair venous return, alter hormonal signaling, and disrupt autonomic regulation through several proposed pathways.20PubMed Central. An Overview of Vascular Compression Syndromes and Associations with Autonomic Dysfunction
These syndromes are particularly relevant for patients who also have connective tissue hypermobility, since looser tissue may predispose veins to compression and abnormal distension.10PubMed Central. May-Thurner syndrome in patients with postural orthostatic tachycardia syndrome and Ehlers-Danlos syndrome The clinical challenge is that vascular compressions often go undiagnosed because they require specific imaging that is not part of a standard POTS workup. Some patients who have not responded to typical POTS treatments have improved after the compression was identified and addressed, but the evidence base is still made up of case series rather than large trials.
COVID-19 Vaccination as a Trigger
Reports of POTS-like symptoms appearing after COVID-19 vaccination have drawn attention, and the evidence so far suggests a real but small signal. A large cohort study of nearly 285,000 vaccinated individuals found that the odds of receiving a new POTS diagnosis were higher in the 90 days after vaccination than in the 90 days before, consistent with a possible association. The same study found that the risk of new POTS was substantially higher after actual SARS-CoV-2 infection than after vaccination.21PubMed Central. Apparent Risks of Postural Orthostatic Tachycardia Syndrome Diagnoses After COVID-19 Vaccination and SARS-Cov-2 Infection A literature review found that POTS-like symptoms after vaccination, reported with Pfizer-BioNTech, Moderna, and Oxford-AstraZeneca vaccines, typically appeared within the first week and were influenced by prior exposure to the virus and the presence of other systemic conditions.22PubMed Central. Postural orthostatic tachycardia syndrome-like symptoms following COVID-19 vaccination Individual case reports have also documented transient POTS after vaccination.23PubMed Central. A case of transient POTS following COVID-19 vaccine
Context matters here. The absolute number of post-vaccination POTS cases is small relative to the hundreds of millions of doses administered, and the risk from the infection itself appears larger. But for someone already predisposed to autonomic dysfunction, the immune activation from any vaccine, not just COVID-19 vaccines, could theoretically serve as a triggering event, much as a natural infection would.
Stress Hormones and Their Role
The stress hormone cortisol turns up at higher-than-normal levels in POTS patients. One study in children found cortisol concentrations were elevated at all measured time points compared with healthy controls.24PubMed. Salivary Cortisol Levels Predict Therapeutic Response to a Sleep-Promoting Method in Children with Postural Tachycardia Syndrome Another study in adults confirmed the finding, showing cortisol levels roughly double those of healthy controls.25PubMed Central. Comparison of cortisol levels in patients with vasovagal syncope and postural tachycardia syndrome Whether chronically elevated cortisol is contributing to POTS or is merely a reflection of the body’s stress response to constant sympathetic overdrive is not yet clear. Cortisol affects fluid balance, blood vessel tone, and immune function, all systems that are disrupted in POTS, so a causal role is biologically plausible. Interestingly, improved sleep was linked to better cortisol patterns and symptom improvement in the pediatric study, hinting that stress-axis management could be a therapeutic avenue worth exploring.
Gut Microbiome Alterations
One of the newer threads in POTS research involves the gut. A study comparing the gut microbiota of people with POTS against healthy controls found that microbial diversity was significantly lower in the POTS group, with distinct shifts in community composition.26Scientific Reports. Gut microbiota composition is altered in postural orthostatic tachycardia syndrome and post-acute COVID-19 syndrome People with post-acute COVID syndrome showed similar but slightly less pronounced shifts. The gut-brain axis, the bidirectional communication highway between intestinal microbes and the central nervous system, is known to influence immune function and autonomic regulation. A disrupted microbiome could theoretically contribute to the low-grade inflammation and immune dysregulation seen in many POTS patients. This research is still early, and no one is suggesting that probiotics will cure POTS, but it opens a window into why gastrointestinal symptoms like nausea, bloating, and motility problems are so common in the condition. Whether the microbiome changes are a cause, a consequence, or a bystander effect of the autonomic dysfunction itself will take larger, longitudinal studies to sort out.